“EVALUATION OF CITALOPRAM AFFECTED THE GENERALIZED ANXIETY DISORDER PARTICIPANTS’ QUALITY OF LIFE”. International Research Journal of Pharmacy, vol. 14, no. 11, Nov. 2023, pp. 21-25, https://doi.org/10.56802/kedfgd52.